These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1675711)
1. European drug regulation--anti-protectionism or consumer protection? Lancet; 1991 Jun; 337(8757):1571-2. PubMed ID: 1675711 [No Abstract] [Full Text] [Related]
2. Consumer protection from an EU regulation on the mandatory labelling of genetically modified food. Clin Lab; 2004; 50(5-6):380-1. PubMed ID: 15209444 [TBL] [Abstract][Full Text] [Related]
3. US and European postmarket clinical data requirements. Donawa M Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495 [TBL] [Abstract][Full Text] [Related]
5. Switzerland: one year's experience with new regulations and a new agency. Voelksen R Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697 [TBL] [Abstract][Full Text] [Related]
6. The challenges of regulating stem cell-based products. von Tigerstrom BJ Trends Biotechnol; 2008 Dec; 26(12):653-8. PubMed ID: 18977047 [TBL] [Abstract][Full Text] [Related]
7. The impact of FDA reform. Trunzo J Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699 [TBL] [Abstract][Full Text] [Related]
8. Regulating drugs for effectiveness and safety: a public health perspective. Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264 [No Abstract] [Full Text] [Related]
9. [The use of nanotechnology in medicinal products in the light of European Union law]. Jurewicz M Pol Merkur Lekarski; 2014 Dec; 37(222):369-72. PubMed ID: 25715580 [TBL] [Abstract][Full Text] [Related]
10. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics. Lodén M; Ungerth L; Serup J Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885 [TBL] [Abstract][Full Text] [Related]
12. Australian and New Zealand governments agree to proceed with the joint regulatory agency for therapeutic products. Moore J J Law Med; 2011 Dec; 19(2):272-4. PubMed ID: 22320002 [No Abstract] [Full Text] [Related]
13. Medical device management. Young S Nurs Manag (Harrow); 1999 May; 6(2):18-21. PubMed ID: 10478078 [No Abstract] [Full Text] [Related]
14. [Historical development of the European legislation on chemicals]. Bolt HM Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1381-6. PubMed ID: 19137213 [TBL] [Abstract][Full Text] [Related]
15. The Safe Medical Devices Act. Williams MA South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188 [TBL] [Abstract][Full Text] [Related]
16. [Organization of the Federal Drug and Medical Products Institute in view of increased European competition]. Kurth R Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):340-4. PubMed ID: 18369569 [No Abstract] [Full Text] [Related]
17. Drug regulation in Australia. Hall RC Med J Aust; 1989 Sep; 151(6):338-40, 343-6. PubMed ID: 2687666 [No Abstract] [Full Text] [Related]
18. Assessing Drug Safety in Children - The Role of Real-World Data. McMahon AW; Dal Pan G N Engl J Med; 2018 Jun; 378(23):2155-2157. PubMed ID: 29874532 [No Abstract] [Full Text] [Related]
19. Herbs and dietary supplements in the European Union: a review of the regulations with special focus on Germany and Poland. Konik EA; Jungling RC; Bauer BA J Diet Suppl; 2011 Mar; 8(1):43-57. PubMed ID: 22432634 [TBL] [Abstract][Full Text] [Related]